» Articles » PMID: 34944905

Local Biomarkers Involved in the Interplay Between Obesity and Breast Cancer

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2021 Dec 24
PMID 34944905
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Obesity is associated with an increased risk of breast cancer, which is the most common cancer in women worldwide (excluding non-melanoma skin cancer). Furthermore, breast cancer patients with obesity have an impaired prognosis. Adipose tissue is abundant in the breast. Therefore, breast cancer develops in an adipose-rich environment. During obesity, changes in the local environment in the breast occur which are associated with breast cancer. A shift towards a pro-inflammatory state is seen, resulting in altered levels of cytokines and immune cells. Levels of adipokines, such as leptin, adiponectin, and resistin, are changed. Aromatase activity rises, resulting in higher levels of potent estrogen in the breast. Lastly, remodeling of the extracellular matrix takes place. In this review, we address the current knowledge on the changes in the breast adipose tissue in obesity associated with breast cancer initiation and progression. We aim to identify obesity-associated biomarkers in the breast involved in the interplay between obesity and breast cancer. Hereby, we can improve identification of women with obesity with an increased risk of breast cancer and an impaired prognosis. Studies investigating mammary adipocytes and breast adipose tissue in women with obesity versus women without obesity are, however, sparse and further research is needed.

Citing Articles

Breast Cancer: Extracellular Matrix and Microbiome Interactions.

Herrera-Quintana L, Vazquez-Lorente H, Plaza-Diaz J Int J Mol Sci. 2024; 25(13).

PMID: 39000333 PMC: 11242809. DOI: 10.3390/ijms25137226.


Circulating C-reactive protein levels as a prognostic biomarker in breast cancer across body mass index groups.

Holm J, Baggesen E, Cronin-Fenton D, Frystyk J, Bruun J, Christiansen P Sci Rep. 2024; 14(1):14486.

PMID: 38914635 PMC: 11196728. DOI: 10.1038/s41598-024-64428-3.


Molecular and serological biomarkers to predict trastuzumab responsiveness in HER-2 positive breast cancer.

Abdullah N, Al-Mansouri L, Ali N, Hadi N J Med Life. 2024; 16(11):1633-1638.

PMID: 38406785 PMC: 10893566. DOI: 10.25122/jml-2023-0163.


The Metabolomic Characteristics and Dysregulation of Fatty Acid Esters of Hydroxy Fatty Acids in Breast Cancer.

Qin L, An N, Yuan B, Zhu Q, Feng Y Metabolites. 2023; 13(11).

PMID: 37999204 PMC: 10673550. DOI: 10.3390/metabo13111108.


Role of adipokines in sarcopenia.

Lu W, Feng W, Lai J, Yuan D, Xiao W, Li Y Chin Med J (Engl). 2023; 136(15):1794-1804.

PMID: 37442757 PMC: 10406092. DOI: 10.1097/CM9.0000000000002255.


References
1.
Ishikawa M, Kitayama J, Nagawa H . Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clin Cancer Res. 2004; 10(13):4325-31. DOI: 10.1158/1078-0432.CCR-03-0749. View

2.
Hibino S, Kawazoe T, Kasahara H, Itoh S, Ishimoto T, Sakata-Yanagimoto M . Inflammation-Induced Tumorigenesis and Metastasis. Int J Mol Sci. 2021; 22(11). PMC: 8196678. DOI: 10.3390/ijms22115421. View

3.
Dietze E, Chavez T, Seewaldt V . Obesity and Triple-Negative Breast Cancer: Disparities, Controversies, and Biology. Am J Pathol. 2017; 188(2):280-290. PMC: 5785535. DOI: 10.1016/j.ajpath.2017.09.018. View

4.
Kolb R, Kluz P, Tan Z, Borcherding N, Bormann N, Vishwakarma A . Obesity-associated inflammation promotes angiogenesis and breast cancer via angiopoietin-like 4. Oncogene. 2018; 38(13):2351-2363. PMC: 6440811. DOI: 10.1038/s41388-018-0592-6. View

5.
Liu M, Zhong S, Kong R, Shao H, Wang C, Piao H . Paeonol alleviates interleukin-1β-induced inflammatory responses in chondrocytes during osteoarthritis. Biomed Pharmacother. 2017; 95:914-921. DOI: 10.1016/j.biopha.2017.09.011. View